Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals

Reported by MarketWatch · Published 21 Sep 2026, 4:58 PM MYT (7 hr ago)

Image: MarketWatch

Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.

Source & full coverage: this summary is aggregated from MarketWatch, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at MarketWatch →

Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals

Summary

More in Markets

AMD hits a major milestone as AI stocks blaze higher

The Three Years Between Retirement and Medicare Are the Cheapest Tax Years a Couple Will Ever See

He Opened His First Roth at 64 With a $100,000 Conversion. At 67 the Growth Was Still Taxable to Withdraw, Because the Five-Year Clock Started Late

U.S. Oil Imports From Venezuela Just Exploded to a 9-Year High — Chevron Could Be the Biggest Winner

Rocket Lab Climbs 7% as Cantor Reiterates $122 Target on Launch Record; Intuitive Machines Jumps 10%, AST SpaceMobile Rises 6%

This is the ‘most underappreciated’ driver for Microsoft’s business, according to one analyst